Study of Patients With Knee Prostheses Treated With Noninvasive Neuromodulation

Study of Patients With Knee Prostheses Treated With Noninvasive Neuromodulation. PRONES Trial

It will consist of a randomized clinical trial with a control group. The sample will be distributed as homogeneously as possible into two groups, which will be randomly divided into a control group, to which the usual general treatment will be applied, and an experimental group, which will be treated with the NESA XSignal device. During the procedure, the subjects will continue to receive the usual care routine.

The main objective will be to evaluate the efficacy of the NESA XSignal device in relation to the improvement of pain, functionality and quality of life in patients who have undergone total knee replacement surgery.

Inclusion Criteria:

• Patients over 18 years of age
• Total knee replacement surgery at the Hospital San Juan de Dios de Tenerife.
• Be able to freely consent to take part in the study.

Exclusion Criteria:

• No contraindications for treatment with NXSignal: pacemakers, internal bleeding, poor skin condition with ulcerations or wounds, acute febrile processes, acute thrombophlebitis and/or electricity phobia.
• Patients with total knee prosthesis of more than 3 months of evolution.
• Patients with total knee prosthesis with complications.